PD-L1 binding polypeptides for imaging
US-12194110-B2 · Jan 14, 2025 · US
This page is not indexed by search engines while we improve data quality.
Wright Martin C patents
Wright Martin C is listed as an inventor on 26 patents in our database. Major assignees and classification codes are summarized below.
| Metric | Value |
|---|---|
| Inventor | Wright Martin C |
| Total patents | 26 |
| First publication | Apr 28, 2015 |
| Latest publication | Jan 14, 2025 |
Notable patents
Publications ranked by popularity score, then publication date.
Pet imaging with pd-l1 binding polypeptides
US-2022347324-A1 · Nov 3, 2022 · US
PET imaging with PD-L1 binding polypeptides
US-11344639-B2 · May 31, 2022 · US
Novel pd-l1 binding polypeptides for imaging
US-2022001040-A1 · Jan 6, 2022 · US
PD-L1 binding polypeptides for imaging
US-11173219-B2 · Nov 16, 2021 · US
Targeted therapeutics based on engineered proteins for tyrosine kinases receptors, including IGF-IR
US-11149077-B2 · Oct 19, 2021 · US
Libraries of modified fibronectin type III tenth domain-containing polypeptides
US-10995131-B2 · May 4, 2021 · US
Bispecific EGFR/IGFIR binding molecules
US-10954286-B2 · Mar 23, 2021 · US
Novel pd-l1 binding polypeptides for imaging
US-2019343972-A1 · Nov 14, 2019 · US
PD-L1 binding polypeptides for imaging
US-10406251-B2 · Sep 10, 2019 · US
Recent patents
Latest publications not already listed above.
Targeted therapeutics based on engineered proteins for tyrosine kinases receptors, including igf-ir
US-2019202894-A1 · Jul 4, 2019 · US
Pet imaging with pd-l1 binding polypeptides
US-2019184042-A1 · Jun 20, 2019 · US
Bispecific egfr/igfir binding molecules
US-2019153069-A1 · May 23, 2019 · US
Methods of treating cancer by administering IGF-IR binding molecules
US-10221232-B2 · Mar 5, 2019 · US
Polynucleotides encoding bispecific EGFR/IGF-IR binding molecules
US-10183987-B2 · Jan 22, 2019 · US
Inhibitors of type 2 vascular endothelial growth factor receptors
US-2018162926-A1 · Jun 14, 2018 · US
Bispecific egfr/igfir binding molecules
US-2018037631-A1 · Feb 8, 2018 · US
Inhibitors of type 2 vascular endothelial growth factor receptors
US-9862758-B2 · Jan 9, 2018 · US
Method of treating cancer by administering EGFR and EGFR/IGFIR binding molecules
US-9771411-B2 · Sep 26, 2017 · US
Novel pd-l1 binding polypeptides for imaging
US-2017258948-A1 · Sep 14, 2017 · US
Targeted therapeutics based on engineered proteins for tyrosine kinases receptors, including igf-ir
US-2017190761-A1 · Jul 6, 2017 · US
Inhibitors of type 2 vascular endothelial growth factor receptors
US-2016297869-A1 · Oct 13, 2016 · US
Inhibitors of type 2 vascular endothelial growth factor receptors
US-9328157-B2 · May 3, 2016 · US
Bispecific egfr/igfir binding molecules
US-2015259398-A1 · Sep 17, 2015 · US
Targeted therapeutics based on engineered proteins for tyrosine kinases receptors, including igf-ir
US-2015252097-A1 · Sep 10, 2015 · US
Bispecific EGFR/IGFIR binding molecules
US-9017655-B2 · Apr 28, 2015 · US
Major assignees
Companies most often associated with this inventor's publications.
| Assignee | Patents |
|---|---|
| Bristol Myers Squibb Co | 26 |
| Bristol-Myers Quibb Company | 1 |
Top CPC classifications
Most common classification codes across this inventor's patents.
| CPC | Patents |
|---|---|
| C07K14/78 | 23 |
| A61P43/00 | 17 |
| A61P35/00 | 17 |
| A61K38/39 | 17 |
| C07K16/2863 | 17 |